Automated immunoassay analyzer Evidence

for clinical diagnosticmultiplexingbiochip array

The Evidence platform is the world’s first Biochip Technology system and has revolutionised laboratory screening worldwide. As the first of its kind, the Evidence brings higher standards of quality, efficiency and reliability. Utilising Randox’s patented Biochip Technology, the Evidence allows simultaneous detection of multiple analytes from a single sample for faster cost effective testing. The Evidence is a fully-automated immunoanalyser using protein Biochip Technology and is suitable for use in larger laboratory settings including, hospital laboratories, clinical, veterinary, forensic and clinical toxicology and pharmaceutical/CRO applications. Why Choose the Evidence? The Evidence platform has the world’s most diverse test menu, more than any other sole supplier with routine and novel markers available. A fully automated system, maximising walk-away time ensuring optimum laboratory The system is applicable to the analysis of multiple matrices, increasing the flexibility and utility of the Evidence. The Evidence has a 180 sample capacity and a throughput of up to 3960 tests per hour. Multiplex testing delivers a fast and cost effective solution compared to traditional methods. Meet the Evidence The Evidence is a combination of the latest technological advances along with an innovative system design, which has resulted in a revolutionary fully automated system for rapid multiplex testing.